Inventor
HUNZIKER DANIEL
CH57 patents
⚠️ This page may combine multiple inventors who share the name “HUNZIKER DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
33 patentsUS6861440B2Mar 1, 2005
DPP IV inhibitors
HOFFMANN LA ROCHE116 citations98
US9802944B2Oct 31, 2017
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE20 citations92
US9493486B2Nov 15, 2016
Diazaspirocycloalkane and azaspirocycloalkane
HOFFMANN LA ROCHE21 citations92
US10633384B2Apr 28, 2020
Diazaspirocycloalkane and azaspirocycloalkane
HOFFMANN LA ROCHE12 citations85
US10669285B2Jun 2, 2020
Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE9 citations84
US10654857B2May 19, 2020
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE10 citations84
US10640472B2May 5, 2020
Phenoxymethyl derivatives
HOFFMANN LA ROCHE10 citations84
US10669268B2Jun 2, 2020
Bicyclic derivatives
HOFFMANN LA ROCHE9 citations83
US10647719B2May 12, 2020
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE10 citations83
US10676446B2Jun 9, 2020
Bicyclic quinazolinone derivatives
HOFFMANN LA ROCHE9 citations82
US11098048B2Aug 24, 2021
Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors
HOFFMANN LA ROCHE2 citations73
US10849881B2Dec 1, 2020
Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl
HOFFMANN LA ROCHE3 citations73
US10913745B2Feb 9, 2021
Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
HOFFMANN LA ROCHE3 citations72
US10889588B2Jan 12, 2021
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE3 citations72
US10800786B2Oct 13, 2020
Bicyclic compounds as ATX inhibitors
HOFFMANN LA ROCHE4 citations72
US10787459B2Sep 29, 2020
Bicyclic compounds as ATX inhibitors
HOFFMANN LA ROCHE4 citations72
US10738053B2Aug 11, 2020
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE5 citations72
US10882857B2Jan 5, 2021
Bicyclic compounds as ATX inhibitors
HOFFMANN LA ROCHE3 citations71
US11059794B2Jul 13, 2021
Heterocyclic compounds useful as dual ATX/CA inhibitors
HOFFMANN LA ROCHE2 citations69
US7678795B2Mar 16, 2010
Pyridazines as 11b-HSD1 inhibitors
HOFFMANN LA ROCHE6 citations63
US7547697B2Jun 16, 2009
Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors
HOFFMANN LA ROCHE2 citations63
US11352330B2Jun 7, 2022
Phenoxymethyl derivatives
HOFFMANN LA ROCHE1 citations62
US7528159B2May 5, 2009
5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
HOFFMANN LA ROCHE2 citations62
US7411093B2Aug 12, 2008
Aminocycloalkanes as DPP-IV inhibitors
HOFFMANN LA ROCHE4 citations62
US7314884B2Jan 1, 2008
DPP IV inhibitors
HOFFMANN LA ROCHE2 citations62
US11673888B2Jun 13, 2023
Bicyclic compounds as ATX inhibitors
HOFFMANN LA ROCHE0 citations61
US12116349B2Oct 15, 2024
Methylquinazolinone derivatives
HOFFMANN LA ROCHE0 citations59
US12509467B2Dec 30, 2025
CGAS inhibiting triazolopyrimidone derivatives
HOFFMANN LA ROCHE0 citations52
US7803819B2Sep 28, 2010
DPP IV inhibitors
HOFFMANN LA ROCHE0 citations52
US7683079B2Mar 23, 2010
4-aminopiperidine derivatives
HOFFMANN LA ROCHE1 citations52
US7507733B2Mar 24, 2009
11b-HSD1 inhibitors for the treatment of diabetes
HOFFMANN LA ROCHE1 citations52
US7482341B2Jan 27, 2009
Pyridines
HOFFMANN LA ROCHE1 citations52
US12570615B2Mar 10, 2026
Quinazolinone derivatives
HOFFMANN LA ROCHE0 citations49
ACKERMANN JEAN
7 patentsUS8097634B2Jan 17, 2012
Azacyclic derivatives
ACKERMANN JEAN23 citations92
US8552024B2Oct 8, 2013
Azacyclic compounds
ACKERMANN JEAN8 citations83
US8329904B2Dec 11, 2012
Azacyclic derivatives
ACKERMANN JEAN8 citations83
US8129423B2Mar 6, 2012
Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitors
ACKERMANN JEAN6 citations72
US8470843B2Jun 25, 2013
Azacyclic compounds
ACKERMANN JEAN0 citations51
US8440710B2May 14, 2013
HSL inhibitors useful in the treatment of diabetes
ACKERMANN JEAN1 citations51
US8389539B2Mar 5, 2013
Azacyclic derivatives
ACKERMANN JEAN1 citations51
HUNZIKER DANIEL
4 patentsUS8722721B2May 13, 2014
SEC-hydroxycyclohexyl derivatives
HUNZIKER DANIEL0 citations51
US8703807B2Apr 22, 2014
Azaspirodecanone compounds
HUNZIKER DANIEL0 citations51
US8450313B2May 28, 2013
2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
HUNZIKER DANIEL0 citations50
US8268820B2Sep 18, 2012
2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
HUNZIKER DANIEL0 citations47
C4 THERAPEUTICS INC
2 patentsBAILLY JACQUES
2 patentsBASILEA PARMACEUTICA AG
1 patentCONTE AURELIA
1 patentShowing the top 50 of 57 patents by PatentIndex Score.